Investors will be keen to see what strategic goals the newly independent pharmaceutical group Indivior (INDV) publishes alongside its inaugural set of results next week. Not much is known about the entity spun out of consumer goods giant Reckitt Benckiser (RB.) in December.
To continue reading, register today
to enjoy limited access to the following:
- Daily trading news
- Funds coverage
- Features on big investment themes
- Comprehensive companies coverage
- Economic analysis